Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS).

Autor: Gronchi A; Sarcoma Unit, Department of Surgery, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy., Judson I; The Institute of Cancer Research, Royal Cancer Hospital, 123 Old Brompton Road, London SW7 3RP, UK., Nishida T; Department of Surgery, E1, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan., Poveda A; Medical Oncology Department, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain., Martin J; Skeletal-Muscle Tumour Committee, Hospital Son Dureta, Palma de Mallorca, Spain., Reichardt P; HELIOS Klinikum Bad Saarow, Pieskower Straße 33, 15526 Bad Saarow, Germany., Casali PG; Adult Sarcoma Medical Treatment Unit, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy., Cesne AL; Department of Medicine, Institut Gustave Roussy, 94805 Villejuif Cedex, France., Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Centre, University of Heidelberg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany., Blay JY; Department of Medicine, Centre Leon Berard, 28, rue Laennec, 69008 Lyon, France. Electronic address: blay@lyon.fnclcc.fr.
Jazyk: angličtina
Zdroj: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2009 May; Vol. 45 (7), pp. 1103-1106. Date of Electronic Publication: 2009 Mar 13.
DOI: 10.1016/j.ejca.2009.02.009
Databáze: MEDLINE
Externí odkaz: